| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC1686 |
| Trial ID | NCT03029273 |
| Disease | Lung Non-Small Cell Carcinoma |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | TAEST16001 |
| HLA | HLA-A*02:01 |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Pilot Study of Affinity-enhanced Anti-NY-ESO-1 TCR Engineered Autologous T Cells in NSCLC Patients |
| Year | 2017 |
| Country | China |
| Company sponsor | Guangzhou Institute of Respiratory Disease |
| Other ID(s) | 2016-63 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||